Dendritic cells (DCs) are myeloid cells bridging the innate and adaptive immune system. By
cross‐presenting tumor‐associated antigens (TAAs) liberated upon spontaneous or therapy …

Chemoimmunotherapy is an emerging paradigm in the clinic for treating several malignant
diseases, such as non-small cell lung cancer, breast cancer, and large B-cell lymphoma …

Co-assembly is a key phenomenon in life, playing a significant role in various biological
processes. In particular, supramolecular composite hydrogels (SMCHs) form through the …

Sphingolipids, crucial components of cellular membranes, play a vital role in maintaining
cellular structure and signaling integrity. Disruptions in sphingolipid metabolism are …

Intratumoral delivery and localized chemotherapy have demonstrated promise in tumor
treatment; however, the rapid drainage of therapeutic agents from well-vascularized tumors …

The successful treatment of oncological malignancies which results in long-term disease
control or the complete eradication of cancerous cells necessitates the onset of adaptive …

Cancer nanomedicine has been an emerging field for drug development against malignant
tumors during the past three decades. A bibliometric analysis was performed to characterize …

The concept of immunogenic cell death (ICD) induced by chemotherapy as a potential
synergistic modality for cancer immunotherapy has been widely discussed. Unfortunately …

Elevated lipid metabolism is one of hallmarks of malignant tumors. Lipids not only serve as
essential structural components of biological membranes but also provide energy and …

Cancer heterogeneity poses a significant hurdle to the successful treatment of the disease,
and is being influenced by genetic inheritance, cellular and tissue biology, disease …